Sinovac Biotech Ltd (SVA) stock
SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.47+0.00 (0.00%)
Close on Nov 18, 2026Market cap $464.94MP/E –Yield 850.08%
Sinovac Biotech revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $386.01M, up 6.8% from the year before. Over ten years it grew 19.1% a year on average. The highest annual figure on record is $19.37B in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $386.01M | +6.8% |
| FY2024 | Dec 31, 2024 | $361.37M | -23.1% |
| FY2023 | Dec 31, 2023 | $470.17M | -68.1% |
| FY2022 | Dec 31, 2022 | $1.47B | -92.4% |
| FY2021 | Dec 31, 2021 | $19.37B | +3692.5% |
| FY2020 | Dec 31, 2020 | $510.62M | +107.5% |
| FY2019 | Dec 31, 2019 | $246.05M | +7.1% |
| FY2018 | Dec 31, 2018 | $229.65M | +31.7% |
| FY2017 | Dec 31, 2017 | $174.35M | +140.7% |
| FY2016 | Dec 31, 2016 | $72.43M | +7.4% |
| FY2015 | Dec 31, 2015 | $67.41M | +7.1% |
| FY2014 | Dec 31, 2014 | $62.93M | -12.3% |
| FY2013 | Dec 31, 2013 | $71.77M | +45.8% |
| FY2012 | Dec 31, 2012 | $49.22M | -13.4% |
| FY2011 | Dec 31, 2011 | $56.84M | +70.2% |
| FY2010 | Dec 31, 2010 | $33.40M | -60.3% |
| FY2009 | Dec 31, 2009 | $84.20M | – |
See a number that looks wrong?